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A defi  ning property of memory CD8 T cells gen-
erated after acute infection or vaccination is long-
term antigen-independent persistence mediated 
by homeostatic turnover (1, 2). Slow, steady self-
renewal of memory CD8 T cells is driven by IL-7 
and IL-15 (3–7). This key memory CD8 T cell 
quality gradually develops as memory CD8 T cells 
diff  erentiate from eff  ector CD8 T cells in the 
  absence of antigen (8, 9). During chronic infec-
tions, however, diff  erentiation of antigen-specifi  c 
CD8 T cells may occur diff  erently. We and oth-
ers have recently demonstrated that the ex-
pression of IL-7 and IL-15 receptors (CD127, 
CD122) can be suboptimal during chronic viral 
infections, and the ability to divide in response to 
IL-7 and IL-15 is compromised in vitro (10–14). 
In addition, when removed from chronically in-
fected mice and adoptively transferred to naive 
mice, memory-phenotype, virus-specifi  c  CD8 
T cells do not undergo homeostatic turnover and 
are not effi     ciently maintained (10). Thus, it is 
  perhaps surprising that virus-specifi  c CD8 T cell 
populations often persist for long periods of time 
during chronic viral infections.
Despite these previous studies, the pathway(s) 
used by antigen-experienced CD8 T cells for 
long-term persistence during chronic infection 
has not been determined. At least four mecha-
nisms may account for the persistence of virus-
specifi  c CD8 T cells during chronic infections: 
(a) IL-7 and IL-15 expressed at diff  erent levels 
(or in a diff   erent manner) in the chronically 
  infected hosts, (b) other cytokines/growth fac-
tors present during chronic infection, perhaps 
associated with persistent infl  ammation, (c) 
continual resupply of antigen-specifi  c CD8 
T cell populations from the naive T cell pool (e.g., 
recent thymic emigrants [RTEs]), and (d) a role 
for viral antigen in T cell maintenance. Deter-
mining which of these mechanisms controls 
  virus-specifi  c CD8 T cell persistence during 
chronic infections will have important implica-
tions for therapeutic manipulations designed to 
augment immunity to persisting pathogens.
 In the current study, we have addressed 
this issue using the lymphocytic choriomenin-
gitis virus (LCMV) model of chronic infection. 
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Effi  cient maintenance of memory CD8 T cells is central to long-term protective immunity. 
IL-7– and IL-15–driven homeostatic proliferation is essential for long-term memory CD8 
T cell persistence after acute infections. During chronic infections, however, virus-specifi  c 
CD8 T cells respond poorly to these cytokines. Yet, virus-specifi  c CD8 T cells often persist 
for long periods of time during chronic infections. We have addressed this apparent para-
dox by examining the mechanism for maintaining virus-specifi  c CD8 T cells during chronic 
infection. We fi  nd that homeostatic cytokines (e.g., IL-7/15), infl  ammatory signals, and 
priming of recent thymic emigrants are not suffi  cient to maintain virus-specifi  c CD8 T cells 
over time during chronic infection. Rather, our results demonstrate that viral peptide is 
required for virus-specifi  c CD8 T cell persistence during chronic infection. Moreover, this 
viral antigen-dependent maintenance results in a dramatically different type of T cell 
division than is normally observed during memory T cell homeostasis. Rather than under-
going slow, steady homeostatic turnover during chronic viral infection, CD8 T cells undergo 
extensive peptide-dependent division, yet cell numbers remain relatively stable. These 
results indicate that antigen-specifi  c CD8 T cell responses during persisting infection are 
maintained by a mechanism distinct from that after acute infection.
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strain of LCMV clone 13 that lacks one of the dominant 
CD8 T cell epitopes (Db/GP33) were used to examine the 
role of antigen versus environmental aspects of infection in 
the maintenance of virus-specifi  c CD8 T cells in chronically 
infected mice. Our data indicate that antigenic peptide was a 
crucial signal necessary for virus-specifi  c CD8 T cell mainte-
nance during chronic infection. The infl  ammatory environ-
ment alone was not suffi   cient for persistence of virus-specifi  c 
CD8 T cells generated during chronic infection. Further, 
congenic adoptive transfer approaches demonstrated that, in 
the presence of persisting antigen, virus-specifi  c CD8 T cell 
populations were effi   ciently maintained without recruitment 
of new thymic emigrants. Finally, the mechanism for main-
taining virus-specifi  c CD8 T cells during chronic infection 
was via extensive antigen-dependent proliferation (>5–6 di-
visions in 1–3 wk) despite stable cell numbers. T cell mainte-
nance associated with such extensive division during chronic 
viral infection contrasts with the slow, IL-7/IL-15–dependent 
homeostatic division observed for memory CD8 T cells 
  generated after acute infection. These results defi  ne a novel 
mechanism of virus-specifi  c CD8 T cell maintenance used 
during chronic infections.
RESULTS
CD122Lo and CD127Lo virus-specifi  c CD8 T cells persist 
during chronic LCMV infection
To compare the persistence of virus-specifi  c CD8 T cells 
generated after acute versus chronic infection, we used 
LCMV infection in mice. Infection of C57BL/6 mice with 
LCMV Armstrong (Arm) causes an acute infection and the 
virus is completely cleared within 8–10 d postinfection (p.i.) 
(15–17). In contrast, infection with LCMV clone 13, a vari-
ant of Arm that diff  ers by only two amino acids and shares all 
T cell epitopes, causes a chronic infection with  2 mo of 
  viremia (15, 16). Thereafter, clone 13 is cleared from most 
tissues, but persists in some reservoirs such as the kidneys for the 
life of the animal (15, 16). After both Arm (acute) and clone 
13 (chronic) infection, Db/GP33 and Db/GP276-specifi  c 
CD8 T cell populations are generated and these virus-specifi  c 
CD8 T cell responses persist at relatively constant levels for 
months to years (Fig. 1 A and references 10, 16). After con-
trol of viremia ( 2–3 mo p.i.), LCMV-specifi  c CD8 T cell 
populations from chronically infected mice were resting and 
phenotypically resembled memory CD8 T cells (e.g., CD44Hi, 
CD69Lo, CD25Lo, granzyme BLo, and CD62LLo; reference 10 
and unpublished data). We and others have previously found 
that the stable number of Db/GP33-specifi  c CD8 T cells in 
the chronically infected mice is maintained despite the low 
levels of CD122 and CD127 expressed by these cells in the 
spleen and blood (10, 12). It remained possible, however, 
that increased expression of these receptors outside of blood 
and spleen may account for T cell persistence. To test whether 
CD127 and CD122 expression might be elevated in other 
tissues, the levels of these cytokine receptors were examined 
on LCMV-specifi  c CD8 T cells from spleen, PBMC, LN, 
BM, and liver at 2–4 mo after either Arm or clone 13 infection 
(Fig. 1 B). Both CD127 and CD122 levels were low in all 
tissues examined during clone 13 infection, whereas the ex-
pression of these cytokine receptors was high on virus-  specifi  c 
CD8 T cells from Arm immune mice (Fig. 1 B). Thus, after 
control of systemic viral replication, virus-specifi  c memory 
phenotype CD8 T cells persist long term in chronically in-
fected mice, but these cells express low levels of CD122 and 
CD127 in multiple tissues.
IL-7 and IL-15 are not required for virus-specifi  c CD8 T cell 
maintenance during chronic LCMV infection
To test directly whether or not IL-7 and IL-15 were neces-
sary for virus-specifi  c CD8 T cell maintenance in vivo dur-
ing chronic infection, IL-15−/− or WT mice were infected 
with either Arm or clone 13. 2–3 mo after infection, WT 
mice were left untreated, whereas IL-15−/− mice were 
treated with an antibody that blocks the interaction of IL-7 
with the αIL-7Rα (A7R34). This approach has been used 
previously to block IL-7 signals in vivo including those es-
sential for normal memory T cell homeostasis (6, 18–20). As 
expected, Db/GP33-specifi  c memory CD8 T cell numbers 
signifi  cantly declined in the blood of Arm immune IL-15−/− 
mice upon initiation of IL-7Rα blockade compared to mice 
with intact IL-15 and IL-7 pathways (Fig. 1 C). The num-
ber of virus-specifi  c CD8 T cells recovered from the spleens 
of αIL-7Rα–treated, IL-15−/− mice was also reduced com-
pared with untreated WT mice (Fig. 1 D), consistent with 
previous studies (5–7). In contrast, Db/GP33-specifi  c CD8 
T cells were effi   ciently maintained in the blood of clone 
13–infected IL-15−/− mice treated with αIL-7Rα antibody, 
and similar numbers of virus-specifi   c CD8 T cells were 
found in the spleens of clone 13–infected WT and αIL-
7Rα–treated IL-15−/− mice (Fig. 1, C and D). When com-
pared directly, it was apparent that the loss of IL-15 and 
IL-7 signals had a substantially greater impact on the main-
tenance of virus-specifi  c memory CD8 T cells from im-
mune mice compared with virus-specifi  c CD8 T cells in 
chronically infected mice (Fig. 1 C). Thus, unlike memory 
CD8 T cells that develop after acute infection, LCMV-
  specifi  c CD8 T cells that persist in chronically infected mice 
do not appear to require IL-7 or IL-15 for effi   cient mainte-
nance in vivo.
Chronic infection with a Db/GP33 variant virus
To examine the mechanism by which virus-specifi  c CD8 
T cells persist during chronic infection, we have used a strain 
of LCMV clone 13 with a mutation in the Db/GP33 epitope 
(Val®Ala at residue 35; V35A) that abolishes binding of the 
GP33 peptide to the Db MHC class I molecule (21). This 
V35A variant virus causes a chronic infection, and serum vi-
rus levels are indistinguishable between mice infected with 
V35A or WT clone 13 (Fig. 2 A). After infection with the 
V35A variant virus no Db/GP33 tetramer+ CD8 T cells 
were detected, whereas virus-specifi  c CD8 T cell responses 
to four other epitopes were essentially unchanged compared 
with WT clone 13 infection (Fig. 2 B).JEM VOL. 204, April 16, 2007  943
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To determine whether the mutant V35A Db/GP33 epit-
ope would activate memory CD8 T cells in vivo, CFSE-
  labeled memory CD8 T cells from Arm immune mice were 
adoptively transferred to mice persistently infected with 
V35A clone 13 after control of viremia. Db/GP33-specifi  c 
memory CD8 T cells failed to expand when adoptively trans-
ferred to V35A-infected mice. Rather, the donor memory 
Db/GP33-specifi  c CD8 T cells underwent homeostatic pro-
liferation typical of antigen-independent memory CD8 
T cells generated after acute infection (Fig. 2 D). (Note that 
slightly faster homeostatic proliferation is observed for mem-
ory CD8 T cells in V35A mice than in naive mice likely re-
fl   ecting the known lymphopenia associated with chronic 
LCMV infection [22–24].) In contrast to the Db/GP33-
  specifi  c population, donor Db/GP276-specifi  c CD8 T cells 
from Arm immune mice underwent dramatic proliferative 
expansion in the same V35A-infected mice. These cells rapidly 
became CFSE negative (Fig. 2 D) consistent with a robust 
response of these memory CD8 T cells to the persisting anti-
gen present in these mice.
Viral peptide is required to maintain virus-specifi  c CD8 
T cells during chronic LCMV infection.
To investigate whether viral peptide versus the chronically 
infected environment was required for virus-specifi  c CD8 
T cell maintenance during persisting infection, groups of con-
genic (Ly5.1+ or Ly5.2+) C57BL/6 mice were infected with 
either WT or the V35A clone 13. After control of viremia 
( 2–3 mo p.i.), CD8 T cells were purifi  ed from the spleens 
of WT clone 13–infected Ly5.2+ mice, and these cells were 
adoptively transferred to congenic (Ly5.1+) mice that had 
been infected with either V35A or WT clone 13 (Fig. 3 A) 
for a similar duration as the donor mice. Db/GP33- and Db/
GP276-specifi  c donor (Ly5.2+) CD8 T cells were monitored 
Figure 1.  Virus-specifi  c CD8 T cells do not require IL-7 and IL-15 
to persist in chronically infected hosts. (A) Longitudinal analysis of 
Db/GP33-specifi  c CD8 T cells in the PBMCs after LCMV Arm or clone 13 
infection. n = 3–9/time point. (B) Analysis of CD127 and CD122 expression 
on Db/GP276+ CD8 T cells from tissues of Arm immune (> day 30 p.i.) and 
clone 13 (chronic)–infected mice ( 2–4 mo p.i.). Shaded histograms rep-
resents clone 13–infected mice, and lines represent Arm immune mice. All 
histograms are gated on Db/GP276+ CD8 T cells. Similar results were ob-
tained for Db/GP33+ CD8 T cells (not depicted). (C) IL-15−/− and WT mice 
were infected with LCMV Arm or clone 13. After 2–3 mo, the IL-15−/− 
mice were treated with 200 μg αIL-7Rα antibody (Ab) i.p every 2–3 d for 
2 wk, and the maintenance of virus-specifi  c CD8 T cells was compared 
with untreated WT mice. Left plot represents Arm-infected αIL-7Rα–
treated IL-15−/− and untreated WT mice. Middle plot represents clone 
13–infected αIL-7Rα–treated IL-15−/− and untreated WT mice. Right plot 
displays a direct comparison of the same Arm and clone 13–infected 
αIL-7Rα–treated IL-15−/− groups from the fi  rst two graphs. All plots show 
Db/GP33-specifi  c CD8 T cell frequency in the blood as a percentage of the 
Db/GP33-specifi  c CD8 T cell frequency on the fi  rst day of treatment. 
Graphs are representative of three independent experiments; n = 8–11/
time point. *, P < 0.05 by unpaired two-tailed t test. (D) Absolute number 
of Db/GP33-specifi  c CD8 T cells in the spleens of Arm immune and clone 13–
infected WT untreated and IL-15−/− αIL-7Rα–treated mice at the end 
of treatment. Graphs are representative of two independent experiments; 
n = 8–10/group. *, P = 0.03 by unpaired two-tailed t test. Error bars 
represent standard error of the mean.944  CD8 T CELL MEMORY DURING CHRONIC INFECTION | Shin et al.
in the blood of the recipient mice over time by tetramer 
staining (Fig. 3 B). This approach allowed two comparisons 
to be made. First, Db/GP33-specifi   c donor CD8 T cells 
were enumerated in V35A versus WT clone 13–infected 
recipients over time. When adoptively transferred to WT 
clone 13–infected mice, donor Db/GP33-specifi  c CD8 T cells 
were effi   ciently maintained for up to 10 wk (Fig. 3 C). In 
contrast, the donor Db/GP33-specifi  c CD8 T cell popula-
tion rapidly disappeared when adoptively transferred to 
chronically infected V35A recipients lacking the Db/GP33 
epitope (Fig. 3 C). Second, donor Db/GP33 and Db/GP276-
specifi  c CD8 T cell populations were monitored in the same 
V35A-infected mice controlling for any possible variation 
between infected recipient groups. In this situation, despite 
the loss of the Db/GP33-specifi  c population, the donor Db/
GP276-specifi  c CD8 T cells persisted effi   ciently in the same 
V35A-infected recipient mice (Fig. 3 D). The diff  erence 
  between the Db/GP33 and Db/GP276 populations was 
  apparent not only in the blood but in both lymphoid and 
nonlymphoid tissues (Fig. 3 E). At the time of transfer, there 
were approximately twice as many donor Db/GP276-  specifi  c 
cells compared with donor Db/GP33-specifi  c CD8 T cells 
(Fig. 3 B and not depicted). 5 wk after transfer nearly ten 
times more donor Db/GP276-specifi  c CD8 T cells than Db/
GP33-specifi  c CD8 T cells were found in the blood (Fig. 
3 B), and greater numbers of Db/GP276+ compared with 
Db/GP33+ CD8 T cells were also recovered from the spleen 
(approximately sixfold), liver (approximately fourfold), and 
BM (approximately fi  vefold) 1–2 mo after transfer (Fig. 3 E). 
Thus, even in the same chronically infected hosts, only those 
CD8 T cell specifi  cities that could interact with cognate anti-
gen were effi   ciently maintained.
Virus-specifi  c CD8 T cells are maintained by extensive 
division during chronic infection
Normally, after acute infection or vaccination, memory CD8 
T cell maintenance is accomplished by slow, steady homeo-
static turnover leading to self-renewal (25). We next wanted 
to determine whether the LCMV-specifi  c CD8 T cells in 
chronically infected mice were dividing in a similar manner. 
As a reference, CFSE-labeled memory CD8 T cells from 
LCMV Arm immune mice were adoptively transferred to 
congenic naive recipient mice. Over the course of 4 wk, the 
donor memory Db/GP33-specifi  c CD8 T cells showed the 
expected slow rate of homeostatic turnover, and by week 4 
after transfer,  50% of these cells had divided approximately 
one to three times (Fig. 4, A, C, and D). To examine the di-
vision profi  les of virus-specifi  c CD8 T cells during chronic 
infection, CD8 T cells from WT clone 13–infected mice 
were labeled with CFSE and adoptively transferred to con-
genic, infection-matched V35A-infected recipients. Division 
was monitored for donor virus–specifi  c CD8 T cells with 
(Db/GP276) and without (Db/GP33) persisting viral anti-
gen. Donor Db/GP33+ cells in the V35A clone 13–infected 
recipients did not divide, and the frequency and number of 
these cells declined in the blood and spleen over 4 wk (Fig. 4, 
A–D and Fig. 3). In contrast, donor Db/GP276-specifi  c 
CD8 T cells in the same recipient mice not only divided, but 
did so at a rate much faster than was observed for normal ho-
meostatic turnover of Arm immune CD8 T cells. By week 3 
Figure 2.  The V35A clone 13 variant virus causes chronic infection 
similar to WT clone 13. C57BL/6 mice were infected with WT or the 
V35A variant clone 13. (A) Virus levels were determined in the blood of 
mice infected with WT and the V35A variant clone 13 strains. (B) Tetramer 
staining of splenocytes on day 8 p.i. Plots are gated on CD8 T cells; 
numbers in quadrants indicate percentages of CD8 T cells staining with the 
indicated tetramer. (C) CD8 T cells from Arm immune (> day 30 p.i.) were 
adoptively transferred into V35A-infected Ly5.1+ B6 mice ( 2–7 mo p.i.). 
Donor Ly5.2+ Db/GP276+ and Db/GP33+ CD8 T cells were monitored in 
the blood. Kinetics of expansion was normalized to numbers at day 5 after 
transfer. n = 3–4 mice per time point. Data are representative of two 
independent experiments. (D) CFSE profi  les are shown for the donor 
(Ly5.2+) Db/GP33 and Db/GP276-specifi  c CD8 T cells in V35A recipients 
3 wk after transfer for the experiment in part C. Plots are gated on CD8+ 
T cells. Histograms are gated on tetramer+ CD8 T cells. The numbers over 
the gates in the histograms represent percentages of tetramer+ CD8 
T cells that have fully diluted their CFSE. Data are representative of two 
independent experiments. Error bars represent standard error of the mean.JEM VOL. 204, April 16, 2007  945
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after transfer, a substantial population of extensively divided 
tetramer+ cells was present, and by week 4 after transfer, half 
or more of the Db/GP276-specifi  c CD8 T cells had diluted 
their CFSE completely (Fig. 4, A–D). Similar division pro-
fi  les were also observed in the spleen, LN, BM, and nonlym-
phoid tissues such as the liver (Fig. 4 B and not depicted). 
The diff  erence between the slow, steady turnover of memory 
CD8 T cells and the extensive division of virus-specifi  c CD8 
T cells in the presence of antigen during chronic infection is 
summarized in Fig. 4 D, where the percentage of virus-
  specifi  c CD8 T cells that were undivided, in divisions 1–5, or 
that had divided to CFSE negative (6+ divisions) is plotted. 
In  1 mo memory CD8 T cells from Arm immune mice ei-
ther remained undivided or were found in divisions 1–5 
(mainly divisions 1 and 2). In contrast, during chronic infec-
tion in the presence of persisting antigen, virus-specifi  c CD8 
T cells were either undivided or had divided to CFSE nega-
tive in the same time frame (Fig. 4, C and D). Thus, during 
chronic LCMV infection it appears that virus- specifi  c CD8 
T cell persistence is accompanied by extensive cell division 
(fi  ve or more divisions) in contrast to memory CD8 T cells 
that persist after acute infection.
DISCUSSION
During persisting infections virus-specifi  c CD8 T cells often 
express low levels of IL-7 and IL-15 receptors and/or re-
spond poorly to IL-7 and IL-15 in vitro (10–13). These pre-
vious studies indicate that virus-specifi  c CD8 T cells generated 
Figure 3.  Virus-specifi  c CD8 T cells from chronically infected mice 
do not persist without cognate antigen. (A) Schematic of experiments. 
Ly5.2+ C57BL/6 mice were infected with WT clone 13, and Ly5.1+ C57BL/6 
were infected with either WT or V35A clone 13 on the same day. 2–3 mo 
later, after control of viremia, CD8 T cells were purifi  ed using magnetic 
beads from spleens of Ly5.2+ mice and equal numbers of Db/GP33+ CD8 
T cells were transferred to Ly5.1+ WT or V35A clone 13–infected recipients. 
(B) Representative analysis of the Db/GP33+ and Db/GP276+ donor 
(Ly5.2+) CD8 T cells in the PBMCs of recipient mice. Numbers are the per-
centages of donor tetramer+ CD8 T cells. Plots are gated on Ly5.2+ CD8 
T cells. (C) Frequency of Db/GP33+ donor cells in the blood of WT clone 13 
and V35A clone 13–infected recipients over time. Difference between 
Db/GP33+ donor cells in WT clone 13 versus V35A clone 13 is signifi  cant 
by unpaired two-tailed t test at last time point (P = 0.008). Graph is 
representative of two independent experiments. (D) Frequency of Db/GP33+ 
and Db/GP276+ donor cells in the blood of V35A clone 13–infected 
recipients. Db/GP33+ CD8 T cells declined signifi  cantly in number over time 
(P < 0.05 by unpaired two-tailed t test). Difference between Db/GP33 and 
Db/GP276 frequency is also signifi  cant at all points after the initial bleed 
(P < 0.05 by unpaired two-tailed t test). Graph represents data from 
fi  ve independent experiments each with 2–3 mice/group. (E) Number of 
tetramer+ CD8 T cells in lymphoid and nonlymphoid tissues. BM represents 
two femurs. Graphs represent two to three independent experiments; 
n = 3–6/group. *, P < 0.04 by unpaired two-tailed t test. Difference between 
Db/GP33+ and Db/GP276+ populations in the bone marrow did not reach 
statistical signifi  cance (P = 0.09 by unpaired two-tailed t test). Dashed 
line represents limit of detection for parts C, D, and E. Error bars represent 
standard error of the mean.946  CD8 T CELL MEMORY DURING CHRONIC INFECTION | Shin et al.
during chronic infection may not develop the same mainte-
nance characteristics as those memory CD8 T cells that per-
sist after acute infection. However, virus-specifi  c T cells after 
acute and chronic LCMV infection incorporate similar levels 
of BrdU during a 1-wk pulse suggesting ongoing cell division 
in vivo (26) notwithstanding the low levels of CD122 and 
CD127. Despite these observations, the mechanism for antigen-
specifi  c CD8 T cell maintenance during persisting infections 
remains poorly understood. In the present study, we have 
defi  ned not only the mechanism of virus-specifi  c CD8 T cell 
maintenance during chronic viral infection, but also uncov-
ered a division pattern that was distinct from that normally 
observed for homeostatic turnover of memory T cells. Our 
studies indicated that viral antigen was necessary for long-
term persistence of virus-specifi  c CD8 T cells during chronic 
infection, and also that the environment of chronic infection, 
including any infl  ammatory signals or altered IL-7 and IL-15 
expression, was not suffi   cient to maintain virus-specifi  c CD8 
T cells in chronically infected mice. It remains possible that 
environmental factors may play an accessory role, but they 
alone cannot sustain virus-specifi  c CD8 T cells during chronic 
LCMV infection.
During chronic LCMV infection many virus-specifi  c 
CD8 T cells had divided more than fi  ve to six times in  1 mo 
in the presence of viral antigen, yet the number of these virus-
specifi  c CD8 T cells numbers remained relatively stable. This 
observation suggests that either a very small subset of CFSEHi 
cells are recruited to divide or that the antigen-driven division 
of this CD8 T cell population is accompanied by extensive 
cell death. This pattern of division may help explain the 
  immunodominance changes and the immune “infl  ation” that has 
been observed during several persisting infections (16, 27, 28). 
A diff  erence between death and division rates during ho-
meostatic proliferation after acute infection may lead to only 
a subtle change in cell numbers because the rate of division is 
slow. In contrast, during chronic infection, where the persist-
ing virus-specifi  c CD8 T cell population undergoes extensive 
division over the course of several weeks, a minor discrepancy 
between the rates of division and death could be amplifi  ed to 
a large change in cell numbers. Therapeutic manipulation of 
Figure 4.  Virus-specifi  c CD8 T cells are maintained by extensive 
proliferation during chronic infection. The experimental approach 
outlined in Fig. 3 A was used to monitor cell division history during 
chronic LCMV infection. (A) Proliferation patterns of donor virus-specifi  c 
CD8 T cells in the blood. Left column indicates homeostatic proliferation 
of memory CD8 T cells from Arm immune mice (> day 30 p.i.) after 
adoptive transfer into naive mice. The middle column shows division 
of Db/GP33-specifi  c CD8 T cells without antigen in the V35A-infected 
recipients, whereas the right column shows the division of the Db/
GP276-specifi  c CD8 T cell population with persisting antigen present in 
the same adoptive hosts. The donor CD8 T cells used for adoptive trans-
ferred were isolated from chronically infected donors 2–3 mo after 
infection. (B) Proliferation of WT clone 13–derived donor virus-specifi  c 
CD8 T cells in the liver of V35A clone 13–infected recipients at 4 wk 
after transfer. (C) Histograms of donor tetramer+ CD8 T cells in the 
PBMCs at 4 wk after transfer. Numbers indicate the percentages of 
virus-specifi  c CD8 T cells that have undergone no division (right gate), 
1–5 divisions (middle gate), and 6+ divisions (left gate). All histograms 
are gated on Ly5.2+CD8+tetramer+ populations. (D) Graphs indicate 
the percentages of tetramer+ CD8 T cells that have undergone 0 divi-
sions, 1–5 divisions, or 6+ divisions. Top two rows represents PBMCs, 
bottom row represents spleen, both at 4 wk after transfer. Panels are 
representative of two independent experiments for Arm immune and 
four independent experiments for chronic infection, each with n = 2–7 
mice/group. A signifi  cantly greater percentage of Db/GP276+ CD8 T cells 
have undergone 6+ divisions in the spleen compared with Db/GP33+ 
CD8 T cells (P = 0.03 by unpaired two-tailed t test). The differences in 
the blood are also statistically signifi  cant with more Db/GP276+ CD8 
T cells that have undergone 6+ divisions and fewer undivided compared 
with Db/GP33+ CD8 T cells (P = 0.03 and P = 0.02, respectively, by 
 unpaired  two-tailed  t test). Error bars represent standard error of 
the mean.JEM VOL. 204, April 16, 2007  947
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the rate of either recruitment into division or death may pro-
vide a novel means to modulate antigen-specifi  c CD8 T cell 
responses to persisting viral antigen.
The CFSE profi  les in the present study reveal populations 
of both extensively divided and completely undivided virus-
specifi  c CD8 T cells during persisting infection. It is unclear 
why some virus-specifi  c CD8 T cells proliferated extensively 
during chronic infection, whereas others failed to divide. The 
transfer of memory CD8 T cells from Arm immune mice to 
chronically infected recipients results in complete division of 
all Db/GP276-specifi  c donor cells (Fig. 2). This observation 
suggests that lack of antigen encounter is an unlikely explana-
tion for the undivided population of virus-specifi  c CD8 
T cells from chronically infected mice. A second possibility is 
that only a subpopulation of the virus-specifi  c CD8 T cells 
generated during chronic infection are capable of the peptide-
dependent division. It will be important to determine whether 
heterogeneity exists in these T cell populations based on anti-
gen-dependent maintenance potential, division history, or 
other factors.
A recent study suggested that ongoing thymic output can 
result in priming of new virus-specifi  c CD8 T cells during 
persisting infections (29). In the current study, we used con-
genically marked donor populations and found that the num-
ber of tetramer+ CD8 T cells remains reasonably stable for 
 10 wk when antigen is present (Fig. 3). These results sug-
gest that RTEs are not necessary to maintain a virus-specifi  c 
CD8 T cell population during chronic LCMV infection. 
This observation is consistent with studies in thymectomized 
mice where virus-specifi  c CD8 T cell populations were sta-
ble for nearly 3 mo during chronic LCMV infection (30). 
However, our results do not exclude a contribution from 
RTEs primed on persisting antigen, and this pathway may be 
quantitatively diff  erent depending on the nature of viral per-
sistence (e.g., presence or absence of viral antigens in the thymus). 
It will also be interesting to determine if a subpopulation of 
recently primed CD8 T cells possesses distinct functional 
characteristics compared with the majority of the antigen-
specifi  c population that has been maintained since early dur-
ing the initial infection.
The present study suggests that during chronic infection 
virus-specifi  c CD8 T cells acquire a mechanism of mainte-
nance distinct from naive CD8 T cells or eff  ector and mem-
ory CD8 T cells generated after acute infection. During 
chronic infection virus-specifi  c CD8 T cells respond poorly 
to IL-7 and IL-15 and rather appear to rely on TCR signals 
for persistence. However, unlike naive CD8 T cells, the 
TCR signal required by virus-specifi  c CD8 T cells during 
chronic infection cannot be supplied by MHC and self-
  peptide alone. Instead, viral antigen is necessary for long-term 
persistence. Unlike memory CD8 T cells that undergo pro-
liferative expansion in response to antigen, virus-specifi  c 
CD8 T cells present during chronic infection undergo exten-
sive division, but the population does not expand dramati-
cally in number in response to low levels of persisting viral 
antigen (compare the Db/GP276 response in Fig. 2 C and 
Fig. 3 D). These observations are consistent with previous 
studies that found reduced proliferative potential of virus-
specifi  c T cells during chronic infection (10, 31, 32), but also 
now extend the implications of this proliferative diff  erence to 
T cell maintenance during chronic infection. This altered re-
sponsiveness to homeostatic signals and to persisting viral an-
tigen suggests that during chronic infections virus-specifi  c 
CD8 T cells undergo a fundamentally diff  erent pattern of dif-
ferentiation compared with memory CD8 T cells that de-
velop in the absence of persisting antigen after acute infection. 
Thus, during chronic viral infection, antigen-specifi  c CD8 T 
cells appear to be “tuned” to respond to low levels of antigen 
in a dramatically diff  erent manner than memory CD8 T cells 
generated after acute infections.
Antigen-dependent T cell maintenance by extensive di-
vision may have relevance to other infectious and noninfec-
tious settings. Many human infections are characterized by 
prolonged viral replication followed by low-grade persis-
tence. Indeed, CD8 T cells specifi  c for EBV and CMV often 
express low levels of CD127 compared with infl  uenza virus-
specifi  c memory CD8 T cells (33). In addition, HIV-specifi  c 
CD8 T cells can have dramatic defects in CD127 expression 
(34–36), and HIV-specifi  c CD8 T cells are poorly maintained 
when antigen is removed by epitope mutation or HAART 
(37–39). In addition to chronic viral infections, persisting 
bacterial and parasitic infections may also lead to the genera-
tion of T cells with altered maintenance properties (40–42). 
Oligoclonal expansions of memory phenotype CD8 T cells 
found in mice have recently been suggested to share some 
similarities with CD8 T cells generated during chronic viral 
infections (43). These CD8 T cells appear to depend on 
MHC molecules for their persistence in vivo rather than ho-
meostatic cytokines (43). Whether T cells in these diff  erent 
scenarios divide in a homeostatic manner or rather by exten-
sive division as described for the LCMV-specifi  c CD8 T cells 
in this study remains to be determined.
In summary, the present work defi  nes specifi  c viral anti-
gen, rather than IL-7 and IL-15, infl  ammatory cytokines, or 
new recruitment from RTEs, as an essential signal that gov-
erns the persistence of virus-specifi   c CD8 T cells during 
chronic LCMV infection in mice. In addition, we have iden-
tifi  ed a new mechanism for this type of antigen-dependent, 
long-term persistence by extensive cellular division without 
dramatic changes in cell numbers. These observations may 
provide a framework to reevaluate a long-standing debate 
about the role of persisting antigen in the maintenance of 
  immunological memory. Finally, the antigen-dependent 
maintenance mechanism described in this study may have 
implications for therapeutic interventions if either the rate of 
proliferation or cell death can be modulated in vivo to alter 
the size or quality of antigen-specifi  c CD8 T cell populations 
during persisting infections.
MATERIALS AND METHODS
Animals and viruses. 4–6-wk-old female C57BL/6 mice were purchased 
from the Jackson Laboratories, and 4–6-wk-old female congenic B6-Ly5.2/Cr 948  CD8 T CELL MEMORY DURING CHRONIC INFECTION | Shin et al.
mice were purchased from National Cancer Institute. IL-15−/− mice were 
originally obtained from Michael Caligiuri (Ohio State University, Colum-
bus, OH) (44). Mice were infected with 2 × 106 PFUs of LCMV clone 13 
or the V35A clone 13 variant virus i.v. or 2 × 105 PFU of LCMV Arm i.p. 
as described (15, 16). The V35A variant of LCMV clone 13 was isolated after 
infection of C57BL/6 mice containing LCMV-specifi  c TCR transgenic T 
cells (P14 cells). In brief, a small number of naive P14 splenocytes was adop-
tively transferred to C57BL/6 mice followed by LCMV clone 13 infection. 
Virus was isolated from viremic mice  1 mo after infection by plaque puri-
fi   cation and sequenced through the GP33-41 encoding region. Several 
clones were identifi  ed with the same Val to Ala mutation at residue 35, 
a mutation that has been previously observed (21). Virus was grown and 
viral titers were determined by plaque assay as described (15, 16). The αIL-
7Rα antibody was purifi  ed by the hybridoma core at the Wistar Institute 
from the supernatant of the A7R34 hybridoma and used as described (20). 
All mice were used in accordance with Institutional Animal Care and Use 
Committee procedures.
Lymphocyte isolation and fl  ow cytometry. Lymphocyte isolation from 
lymphoid and nonlymphoid tissues and surface and intracellular stains were 
performed as previously described (10, 16). All antibodies were purchased 
from BD Biosciences except for CD127 (eBioscience), Ly5.2 (eBioscience), 
and granzyme B (Caltag). MHC class I peptide tetramers were made and 
used as described previously (10, 16).
CFSE labeling and adoptive transfers. After WT clone 13 or V35A 
clone 13–infected mice were no longer viremic (2–3 mo after infection), 
spleens were harvested from WT clone 13 donor mice. CD8 T cells were 
purifi  ed from splenocytes using magnetic beads (MACS beads; Miltenyi 
Biotec). In brief, splenocytes were labeled with magnetic beads specifi  c for 
CD8α and then run through a MACS LS separation column (Miltenyi Biotec) 
according to the manufacturer’s protocol. The purifi  ed CD8 T cells were 
then labeled with CFSE as described previously (10, 16). Purifi  ed CD8 T 
cells were adoptively transferred i.v. to each recipient mouse. Between 
2–2.5 × 105 Db/GP33-specifi  c CD8 T cells were transferred in the experi-
ments shown. In each individual experiment identical numbers of Db/GP33 
tetramer+ CD8 T cells were adoptively transferred to each separate recipient 
mouse. Donor populations were monitored in the peripheral blood by retro-
orbital blood collection as described previously (10).
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